| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |